https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

CARTITUDE-1 trial reveals cilta-cel’s potential in achieving long-term remission for relapsed/refractory multiple myeloma, sparking discussions on curative possibilities.

administrator

Related Articles